Cindy Berejikian
Operationeel Directeur bij MINERALYS THERAPEUTICS, INC.
Profiel
Cindy Berejikian is currently the Executive Vice President-Operations at Mineralys Therapeutics, Inc. She previously worked as the Director & Global Program Manager at Amgen, Inc. and as the Vice President-Program Management at Otonomy, Inc. Ms. Berejikian holds an MBA degree from the University of California, Los Angeles and an undergraduate degree from the University of California, Santa Barbara.
Actieve functies van Cindy Berejikian
Bedrijven | Functie | Begin |
---|---|---|
MINERALYS THERAPEUTICS, INC. | Operationeel Directeur | - |
Eerdere bekende functies van Cindy Berejikian
Bedrijven | Functie | Einde |
---|---|---|
AMGEN INC. | Directeur/Bestuurslid | - |
OTONOMY | Corporate Officer/Principal | - |
Opleiding van Cindy Berejikian
University of California, Los Angeles | Masters Business Admin |
University of California, Santa Barbara | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
MINERALYS THERAPEUTICS, INC. | Health Technology |
AMGEN INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Otonomy, Inc.
Otonomy, Inc. BiotechnologyHealth Technology Otonomy, Inc. operates as a biopharmaceutical company. engages in the development of therapeutics for neurotology. The firm’s product pipeline includes OTIVIDEX (dexamethasone) Meniere's disease, OTIPRIO (ciprofloxacin otic suspension) acute otitis media with tubes (AOMT), OTO-313 (gacyclidine) tinnitus, OTO-413 (BDNF) hidden hearing Loss, OTO-510 (otoprotectant) prevent CIHL, OTO-6XX (hair cell regeneration) severe hearing loss. It operates under the Otiprio brand. The company was founded by Jay B. Lichter, Jeffrey Harris, Rick Friedman, and Allen F. Ryan on May 6, 2008 and is headquartered in San Diego, CA. | Health Technology |